155 related articles for article (PubMed ID: 36795510)
41. Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites.
Sola-Vera J; Miñana J; Ricart E; Planella M; González B; Torras X; Rodríguez J; Such J; Pascual S; Soriano G; Pérez-Mateo M; Guarner C
Hepatology; 2003 May; 37(5):1147-53. PubMed ID: 12717396
[TBL] [Abstract][Full Text] [Related]
42. Optimal Paracentesis Volume for Terminally Ill Cancer Patients With Ascites.
Ito T; Yokomichi N; Ishiki H; Kawaguchi T; Masuda K; Tsukuura H; Funaki H; Suzuki K; Oya K; Nakagawa J; Mori M; Yamaguchi T
J Pain Symptom Manage; 2021 Nov; 62(5):968-977. PubMed ID: 33933616
[TBL] [Abstract][Full Text] [Related]
43. Endoscopic ultrasound-guided fine-needle aspiration of ascites.
DeWitt J; LeBlanc J; McHenry L; McGreevy K; Sherman S
Clin Gastroenterol Hepatol; 2007 May; 5(5):609-15. PubMed ID: 17336593
[TBL] [Abstract][Full Text] [Related]
44. Comparison of midodrine and albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients: a randomized pilot study.
Hamdy H; ElBaz AA; Hassan A; Hassanin O
J Clin Gastroenterol; 2014 Feb; 48(2):184-8. PubMed ID: 23842215
[TBL] [Abstract][Full Text] [Related]
45. Feasibility of a fast-track randomized controlled trial of cell-free and concentrated ascites reinfusion therapy for patients with refractory malignant ascites.
Yokomichi N; Imai K; Sakamoto M; Horiki M; Yamauchi T; Miwa S; Inoue S; Uneno Y; Suzuki H; Wada T; Ichikawa Y; Morita T
BMC Cancer; 2022 Feb; 22(1):218. PubMed ID: 35227250
[TBL] [Abstract][Full Text] [Related]
46. The clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations.
Pericleous M; Sarnowski A; Moore A; Fijten R; Zaman M
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):e10-8. PubMed ID: 26671516
[TBL] [Abstract][Full Text] [Related]
47. Peritoneal catheter site metastasis in a patient with advanced ovarian cancer.
Ramirez I; Bansal N; Hoffman M
Am J Hosp Palliat Care; 2012 May; 29(3):241-2. PubMed ID: 21606122
[TBL] [Abstract][Full Text] [Related]
48. [Ascitic fluid puncture in the treatment of severe forms of ovarian hyperstimulation syndrome].
Machac S; Dostál J; Oborná I; Zahradnícková V; Brezinová J; Labanová M; Kudela M
Ceska Gynekol; 2001 Sep; 66(5):333-6. PubMed ID: 11732230
[TBL] [Abstract][Full Text] [Related]
49. [Paracentesis].
Assist Inferm Ric; 2006; 25(4):233-5. PubMed ID: 17328484
[No Abstract] [Full Text] [Related]
50. [Puncture of ascites: abdominal paracentesis].
Bosshard S; Müllhaupt B
Praxis (Bern 1994); 2012 Jun; 101(12):757-64, 766; quiz 765. PubMed ID: 22669777
[No Abstract] [Full Text] [Related]
51. Home-based drainage of refractory ascites by a permanent-tunneled peritoneal catheter can safely replace large-volume paracentesis.
Solbach P; Höner Zu Siederdissen C; Taubert R; Ziegert S; Port K; Schneider A; Hueper K; Manns MP; Wedemeyer H; Jaeckel E
Eur J Gastroenterol Hepatol; 2017 May; 29(5):539-546. PubMed ID: 28350743
[TBL] [Abstract][Full Text] [Related]
52. Safety, complications and outcome of large volume paracentesis with or without albumin therapy in children with severe ascites due to liver disease.
Sen Sarma M; Yachha SK; Bhatia V; Srivastava A; Poddar U
J Hepatol; 2015 Nov; 63(5):1126-32. PubMed ID: 26134185
[TBL] [Abstract][Full Text] [Related]
53. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
Appenrodt B; Wolf A; Grünhage F; Trebicka J; Schepke M; Rabe C; Lammert F; Sauerbruch T; Heller J
Liver Int; 2008 Aug; 28(7):1019-25. PubMed ID: 18410283
[TBL] [Abstract][Full Text] [Related]
54. Ascitic fluid filtration and intravenous infusion versus total-volume paracentesis with infusion of plasma expander in cirrhosis with tense or intractable ascites.
Mehta NN; Abraham P; Ashar VJ; Shikare SS; Savant SS; Karnad DR; Mistry FP
Indian J Gastroenterol; 1998; 17(3):93-6. PubMed ID: 9695389
[TBL] [Abstract][Full Text] [Related]
55. Ascites: diagnosis and management.
Hou W; Sanyal AJ
Med Clin North Am; 2009 Jul; 93(4):801-17, vii. PubMed ID: 19577115
[TBL] [Abstract][Full Text] [Related]
56. Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1.
Yamaguchi H; Kitayama J; Emoto S; Ishigami H; Ito T; Hanafusa N; Watanabe T
Eur J Surg Oncol; 2015 Jul; 41(7):875-80. PubMed ID: 25986856
[TBL] [Abstract][Full Text] [Related]
57. Ascites.
Neighbor ML
Emerg Med Clin North Am; 1989 Aug; 7(3):683-97. PubMed ID: 2663463
[TBL] [Abstract][Full Text] [Related]
58. Malignant ascites symptom cluster in patients referred for paracentesis.
Husain A; Bezjak A; Easson A
Ann Surg Oncol; 2010 Feb; 17(2):461-9. PubMed ID: 19866240
[TBL] [Abstract][Full Text] [Related]
59. Ascites in Children.
Bavdekar A; Thakur N
Indian J Pediatr; 2016 Nov; 83(11):1334-1340. PubMed ID: 27278239
[TBL] [Abstract][Full Text] [Related]
60. Pocket ultrasound device as a complement to physical examination for ascites evaluation and guided paracentesis.
Keil-Ríos D; Terrazas-Solís H; González-Garay A; Sánchez-Ávila JF; García-Juárez I
Intern Emerg Med; 2016 Apr; 11(3):461-6. PubMed ID: 26895032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
